EVALUATION OF INHALER PERCEPTION AND PREFERENCE OF SPIROMAX®, EASYHALER®, AND TURBUHALER® DEVICES (FINHALER)

Author(s)

Sandler N¹, Holländer J¹, Långström D¹, Santtila P¹, Saukkonen A², Torvinen S³
¹Åbo Akademi University, Turku, Finland, ²Teva Pharmaceuticals Finland, Espoo, Finland, ³Teva Pharmaceuticals Europe B.V., Amsterdam, The Netherlands

Presentation Documents

PMD106-sandler-n-sup-1-sup-hollander-j-sup-1-sup-strong-u-langstrom-d-u-sup-1-sup-strong-santtila-p-sup-1-sup-saukkonen-a-sup-2-sup-torvinen-s-sup-3-sup-br-sup-1-sup-abo-akademi-university-turku-finland-sup-2-sup-teva-pharmaceuticals-finlan ...

OBJECTIVES: Patient preference and overall satisfaction with their inhaler is correlated with improved adherence, better clinical outcomes and reduced costs. This single-site, cross-over study evaluated preference with dry powder inhalers, Spiromax^®, Easyhaler^® and Turbuhaler^®

Conference/Value in Health Info

2015-11, ISPOR Europe 2015, Milan, Italy

Value in Health, Vol. 18, No. 7 (November 2015)

Code

PMD106

Topic

Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance, Stated Preference & Patient Satisfaction

Disease

Respiratory-Related Disorders

Presentation